Nemolizumab [CAS 1476039-58-3]
Partner: MedChemexpress LLC
| CAS No: | 1476039-58-3 |
| Applications: | COVID-19-immunoregulation |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Nemolizumab] |
| Purity: | 95.56 |
| Description: | Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD)[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
